Alain Kentos
About
In The Last Decade
Alain Kentos
56 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Hematology 330
- Epidemiology 288
- Oncology 284
- Public Health, Environmental and Occupational Health 281
- Molecular Biology 264
Countries citing papers authored by Alain Kentos
This map shows the geographic impact of Alain Kentos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Kentos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Kentos more than expected).
Fields of papers citing papers by Alain Kentos
This network shows the impact of papers produced by Alain Kentos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Kentos. The network helps show where Alain Kentos may publish in the future.
Co-authorship network of co-authors of Alain Kentos
This figure shows the co-authorship network connecting the top 25 collaborators of Alain Kentos. A scholar is included among the top collaborators of Alain Kentos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Kentos. Alain Kentos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | BHS guidelines for the treatment of marginal zone lymphomas | 2 |
| 3 | Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). | 0 |
| 4 | 9 | |
| 5 | 82 | |
| 6 | 4 | |
| 7 | 54 | |
| 8 | 7 | |
| 9 | Rituximab therapy for immune anemia and thrombocytopenia: A Belgian registry run by the red cell subcomittee of the belgian society for hematology | 1 |
| 10 | 13 | |
| 11 | 31 | |
| 12 | La drépanocytose: une affection exotique ou un problème de santé publique en Belgique? | 5 |
| 13 | 2 | |
| 14 | Anti-CD20 monoclonal antibody as first-line treatment of post-transplant B-lymphoproliferative disorders in solid organ transplant recipients. A report of 8 cases observed in a single center | 4 |
| 15 | 30 | |
| 16 | 8 | |
| 17 | 26 | |
| 18 | 26 | |
| 19 | 42 | |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.